Prevalence of Candida dubliniensis Fungemia in Argentina: Identification by a Novel Multiplex PCR and Comparison of Different Phenotypic Methods

Bosco-Borgeat, Maria; Taverna, Constanza; Cordoba, Susana; Isla, Maria; Murisengo, Omar; Szusz, Wanda; Vivot, Walter; Davel, Graciela
November 2011
Mycopathologia;Nov2011, Vol. 172 Issue 5, p407
Academic Journal
Candida dubliniensis is an emerging pathogen that can cause invasive disease in patients who have a variety of clinical conditions. C. dubliniensis is often misidentified as Candida albicans by clinical laboratories. In Argentina, incidence data are still scarce, and only one systemic infection has been reported. This study aims to determine the prevalence of C. dubliniensis in blood samples in Argentina, to evaluate a novel PCR multiplex as well as several phenotypic methods for the identification of this yeast, and to know the susceptibility profile of isolates against seven antifungal drugs. We have found that prevalence in Argentina appears to be lower than that reported in other countries, occurring only in 0.96% of the Candidemia cases recovered in 47 hospitals during a 1-year period. All C. dubliniensis clinical isolates included in this study were genetically identical when comparing ITS genes sequences. This is in agreement with the previous studies suggesting little genetic variation within this species. The novel multiplex PCR proved to be 100% sensitive and specific for the identification of C. dubliniensis. Therefore, we propose its use as a rapid and inexpensive method for laboratories having access to molecular techniques. Although no single phenotypic test has proved to be infallible, both colony morphology on tobacco agar, as well as abundant chlamydospore formation on both tobacco agar and on sunflower seed agar, may be used as a presumptive differentiation method in routine mycology laboratories. It has been suggested that C. dubliniensis may have higher propensity to develop azole antifungal drug resistance than C. albicans. In this study, one of the five clinical isolates of C. dubliniensis was resistant to fluconazole.


Related Articles

  • Use of CHROMagar Candida for the presumptive identification of Candida species directly from clinical specimens in resource-limited settings. Nadeem, Sayyada Ghufrana; Hakim, Shazia Tabassum; Kazmi, Shahana Urooj // Libyan Journal of Medicine;Mar2010, Vol. 5 Issue 5, p1 

    Introduction: Identification of yeast isolated from clinical specimens to the species level has become increasingly important. Ever-increasing numbers of immuno-suppressed patients, a widening range of recognized pathogens, and the discovery of resistance to antifungal drugs are contributing...

  • Novel high-throughput screen against Candida albicans identifies antifungal potentiators and agents effective against biofilms. LaFleur, Michael D.; Lucumi, Edinson; Napper, Andrew D.; Diamond, Scott L.; Lewis, Kim // Journal of Antimicrobial Chemotherapy (JAC);Apr2011, Vol. 66 Issue 4, p820 

    Objectives: Microbial adhesion and biofilms have important implications for human health and disease. Candida albicans is an opportunistic pathogen which forms drug-resistant biofilms that contribute to the recalcitrance of disease. We have developed a high-throughput screen for...

  • Amino Acid Residues Affecting Drug Pump Function in Candida albicans. Holmes, Ann R.; Tsao, Sarah; Lamping, Erwin; Niimi, Kyoko; Monk, Brian C.; Tanabe, Koichi; Niimi, Masakazu; Cannon, Richard D. // Japanese Journal of Medical Mycology;Dec2006, Vol. 47 Issue 4, p275 

    Membrane-located drug transporters are important components in the multidrug resistance of microbial cells and human tissues. In fungi, clinically important resistance to antifungal drugs most often results from the over-expression of efflux pump proteins in the plasma membrane of the resistant...

  • Design of a Simple Model of Candida albicans Biofilms Formed under Conditions of Flow: Development, Architecture, and Drug Resistance. Priya Uppuluri; Ashok Chaturvedi; Jose Lopez-Ribot // Mycopathologia;Sep2009, Vol. 168 Issue 3, p101 

    Abstract   Candida albicans biofilms on most medical devices are exposed to a flow of body fluids that provide water and nutrients to the fungal cells. While C. albicans biofilms grown in vitro under static conditions have been exhaustively studied, the same is not true for biofilms...

  • Antifungals: Need to Search for a New Molecular Target. SANGAMWAR, A. T.; DESHPANDE, U. D.; PEKAMWAR, S. S. // Indian Journal of Pharmaceutical Sciences;2008, Vol. 70 Issue 4, p423 

    In the 1990s, drug resistance has become an important problem in a variety of infectious diseases including human immunodefi ciency virus infection, tuberculosis, and other bacterial infections which have profound effects on human health. At the same time, there have been dramatic increase in...

  • Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.  // Journal of Invasive Fungal Infections;2010, Vol. 4 Issue 3, p117 

    Fluconazole-resistant Candida spp. are increasingly incriminated in invasive Candida infections in cancer patients, including candidemia. In this study, patients with hematological malignancies were more likely to have been infected with non-albicans Candida isolates if they had received prior...

  • Antifungal activity of posaconazole against Candida spp. and non-Candida clinical yeasts isolates. Carrillo-Muñoz, Alfonso Javier; Tur-Tur, Cristina; Hernández-Molina, Juan M.; Quindós, Guillermo; Marcos-Arias, Cristina; Eraso, Elena; Cárdenes, Delia; Ortiz-Maestro, Oscar; Santos, Patricia; Estivill, Dolors; Guardia, Celia; Giusiano, Gustavo // Revista Española de Quimioterapia;sep2010, Vol. 23 Issue 3, p122 

    The in vitro antifungal activity of posaconazole was tested against 315 yeast clinical isolates and 11 ATCC reference strains by means an agar diffusion method (Neosensitabs, Rosco, Denmark) based in CLSI M44-A2 document. Posaconazole activity was excellent against Cryptococcus and Rhodotorula...

  • SYNERGISM BETWEEN CASSIA FISTULA AND FLUCONAZOLE; "A NEW APPROACH AGAINST CANDIDIASIS". Bansal, Yogesh; Saini, Pratap; Bansa, Kirti // International Journal of Pharmaceutical Sciences & Research;Mar2014, Vol. 5 Issue 3, p989 

    Natural products have great potential against microbes and can be used to overcome the problem of drug resistant pathogens. They are helpful in reducing the toxicity of existing antifungal compounds. This present in vitro study demonstrated the synergistic effectiveness of Cassia fistula (CF)...

  • Effects of Mentha suaveolens Essential Oil Alone or in Combination with Other Drugs in Candida albicans. Stringaro, Annarita; Vavala, Elisabetta; Colone, Marisa; Pepi, Federico; Mignogna, Giuseppina; Garzoli, Stefania; Cecchetti, Serena; Ragno, Rino; Angiolella, Letizia // Evidence-based Complementary & Alternative Medicine (eCAM);2014, Vol. 2014, p1 

    Candidosis is the most important cause of fungal infections in humans. The yeast Candida albicans can form biofilms, and it is known that microbial biofilms play an important role in human diseases and are very difficult to treat. The prolonged treatment with drugs has often resulted in failure...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics